Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-04

FDA Approved: CRINONE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CRINONE (progesterone) submitted by Allergan, Inc. under NDA 020701. The action approves a supplement to the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRINONE (Progesterone)

Snippet

SUPPL AP for CRINONE (PROGESTERONE)